PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21466783-0	2011	Oral glucosamine increases expression of transforming growth factor beta1 (TGFbeta1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity.	Glucosamine	5-16	transforming growth factor, beta 1	Rattus norvegicus	41-73	
21466783-0	2011	Oral glucosamine increases expression of transforming growth factor beta1 (TGFbeta1) and connective tissue growth factor (CTGF) mRNA in rat cartilage and kidney: implications for human efficacy and toxicity.	Glucosamine	5-16	transforming growth factor, beta 1	Rattus norvegicus	75-83	
14559714-4	2004	We previously showed that the high-glucose-mediated fibronectin and laminin synthesis in MES cells is mediated by the HBP and that GlcN is more potent than glucose in inducing TGF-beta1 promoter luciferase activity.	Glucosamine	131-135	transforming growth factor, beta 1	Rattus norvegicus	176-185	
28214084-0	2017	IL-10 and TGF-beta: Roles in chondroprotective effects of Glucosamine in experimental Osteoarthritis?	Glucosamine	58-69	transforming growth factor, beta 1	Rattus norvegicus	10-18	
10746823-9	2000	Glucosamine was more potent than glucose, with 3 mM stimulating up to a 4-fold increase in TGFbeta1-transcriptional activity.	Glucosamine	0-11	transforming growth factor, beta 1	Rattus norvegicus	91-99	
33345901-6	2021	D-Glucosamine did not significantly alter body weight, blood glucose or serum insulin levels at any dose tested after 13 weeks exposure, but did increase urinary TGFbeta1 concentrations.	Glucosamine	0-13	transforming growth factor, beta 1	Rattus norvegicus	162-170	
32039769-9	2020	Glucosamine was more potent than glucose, with 3 mM stimulating up to a 4-fold increase in TGFbeta1-transcriptional activity.	Glucosamine	0-11	transforming growth factor, beta 1	Rattus norvegicus	91-99	
28214084-3	2017	We investigated the mechanism of action of glucosamine treatment through interleukin-10 (Il-10) and transforming growth factor beta-1 (TGF beta-1).	Glucosamine	43-54	transforming growth factor, beta 1	Rattus norvegicus	100-133	
28214084-3	2017	We investigated the mechanism of action of glucosamine treatment through interleukin-10 (Il-10) and transforming growth factor beta-1 (TGF beta-1).	Glucosamine	43-54	transforming growth factor, beta 1	Rattus norvegicus	135-145	
28214084-14	2017	On the other hand, the mean serum level of TGF beta-1 was significantly decreased in the GlcN treated groups when compared to the OA group (P value<0.0001).	Glucosamine	89-93	transforming growth factor, beta 1	Rattus norvegicus	43-53